Publication

Investigation leading to CMA's largest fine being imposed on Pfizer leads UK government to legislate to allow them to intervene in the market for pharmaceuticals, medical devices and medical services

Investigation leading to CMA's largest fine being imposed on Pfizer leads UK government to legislate to allow them to intervene in the market for pharmaceuticals, medical devices and medical services

By | 14 Dec 2016

The Competition and Markets Authority has published its decision to impose a fine of nearly £90M on Pfizer and its distributor, Flynn Pharma in relation to huge price inflation in the UK market.

Publication

Avoiding a VW moment

Avoiding a VW moment

By | 25 Sep 2015

The VW "defeat devices" story that broke this week is (another) reminder of how badly wrong things can go for businesses that do not effectively map and manage their regulatory risks.

Publication

Food for thought: Mapping your regulatory risks

Food for thought: Mapping your regulatory risks

By , and | 17 Sep 2015

This week, the spotlight is on key regulatory risk issues currently faced by companies in the food and drink sector. Today we focus on how to go about mapping your regulatory risks.

Publication

Food for thought: advertising and labelling

Food for thought: advertising and labelling

By , and | 15 Sep 2015

This week, the spotlight is on key regulatory risk issues currently faced by companies in the food and drink sector. Today we focus on advertising and labelling.

Publication

Food for thought: nutrition and health claims

Food for thought: nutrition and health claims

By , and | 14 Sep 2015

This week, the spotlight is on key regulatory risk issues currently faced by companies in the food and drink sector. Today we focus on nutrition and health claims.

Publication

Takeover politics

Takeover politics

By | 02 May 2014

A look at the EU and UK merger control rules, and in particular, the opportunities for political interventions in order to protect what is perceived to be the national interest.

Publication

Just saying no

Just saying no

By | 22 Nov 2013

A supplier in a dominant position that refuses to continue to meet the ordinary orders of an existing customer risks falling foul of Article 102 TFEU.

Publication

Full steam ahead on France medtech and pharmaceutical regulatory reforms

Full steam ahead on France medtech and pharmaceutical regulatory reforms

By , and | 07 Nov 2013

From 3rd October 2013, the French High Health Authority was given authorisation to carry out medico-economic evaluations of pharmaceutical products and medical devices in France.

Publications RSS